COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,296,030 | +3.7% | 1,579,240 | -0.3% | 0.02% | +8.7% |
| Q2 2023 | $34,024,963 | -8.6% | 1,583,293 | +2.1% | 0.02% | -14.8% |
| Q1 2023 | $37,209,402 | -4.0% | 1,551,038 | -7.2% | 0.03% | -6.9% |
| Q4 2022 | $38,768,754 | +37.3% | 1,671,067 | -5.2% | 0.03% | +31.8% |
| Q3 2022 | $28,236,000 | -8.3% | 1,762,600 | +1.4% | 0.02% | -4.3% |
| Q2 2022 | $30,802,000 | +6.7% | 1,738,291 | +22.6% | 0.02% | +27.8% |
| Q1 2022 | $28,860,000 | +18.3% | 1,417,513 | +8.6% | 0.02% | +20.0% |
| Q4 2021 | $24,391,000 | +16.8% | 1,305,743 | +23.5% | 0.02% | +7.1% |
| Q3 2021 | $20,878,000 | -14.4% | 1,057,611 | +2.5% | 0.01% | -12.5% |
| Q2 2021 | $24,394,000 | +45.4% | 1,031,927 | +45.7% | 0.02% | +33.3% |
| Q1 2021 | $16,781,000 | +123.8% | 708,073 | +89.2% | 0.01% | +100.0% |
| Q4 2020 | $7,498,000 | – | 374,336 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |